The deal range was $30.00-$31.00. Leerink, TD Cowen, Guggenheim, Wells Fargo and LifeSci Capital acted as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPT:
- Rapt Therapeutics announces common stock offering, no amount given
- Rapt Therapeutics price target raised to $48 from $38 at Wells Fargo
- Rapt Therapeutics price target raised to $60 from $41 at Clear Street
- RAPT Therapeutics Reports Positive Phase 2 Trial Results
- Rapt Therapeutics price target raised to $58 from $35 at Barclays